Base de dados : MEDLINE
Pesquisa : E01.370.372.250.250.225 [Categoria DeCS]
Referências encontradas : 2917 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 292 ir para página                         

  1 / 2917 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28449424
[Au] Autor:Bang BW; Park JS; Kim HK; Shin YW; Kwon KS; Kwon HY; Baek JH; Lee JS
[Ad] Endereço:Divisions of Gastroenterology, Inha University School of Medicine, Incheon, Korea.
[Ti] Título:Fecal Microbiota Transplantation for Refractory and Recurrent Infection: A Case Series of Nine Patients.
[So] Source:Korean J Gastroenterol;69(4):226-231, 2017 Apr 25.
[Is] ISSN:2233-6869
[Cp] País de publicação:Korea (South)
[La] Idioma:eng
[Ab] Resumo:Background/Aims: Fecal microbiota transplantation (FMT) is a highly effective therapy for refractory and recurrent infection (CDI). Despite its excellent efficacy and recent widespread use, FMT has not been widely used in South Korea thus far. We describe our experience with FMT to treat refractory/recurrent CDI. Methods: We conducted a chart review of patients who underwent FMT for refractory/recurrent CDI at Inha University Hospital, between March 2014 and June 2016. The demographic information, treatment data, and adverse events were reviewed. FMT was administered via colonoscopy and/or duodenoscopy. All stool donors were rigorously screened to prevent infectious disease transmission. Results: FMT was performed in nine patients with refractory/recurrent CDI. All patients were dramatically cured. Bowel movement was normalized within one week after FMT. There were no procedure-related adverse events, except aspiration pneumonia in one patient. During the follow-up period (mean 11.4 months), recurrence of CDI was observed in one patient at one month after FMT due to antibiotics. Conclusions: FMT is a safe, well-tolerated and highly effective treatment for refractory/recurrent CDI. Although there are many barriers to using FMT, we expect that FMT will be widely used to treat refractory/recurrent CDI in South Korea.
[Mh] Termos MeSH primário: Infecções por Clostridium/terapia
Enterocolite Pseudomembranosa/terapia
Transplante de Microbiota Fecal
[Mh] Termos MeSH secundário: Idoso
Idoso de 80 Anos ou mais
Antibacterianos/uso terapêutico
Infecções por Clostridium/diagnóstico
Infecções por Clostridium/tratamento farmacológico
Colonoscopia
Duodenoscopia
Enterocolite Pseudomembranosa/diagnóstico
Enterocolite Pseudomembranosa/tratamento farmacológico
Transplante de Microbiota Fecal/efeitos adversos
Fezes/microbiologia
Feminino
Seres Humanos
Masculino
Meia-Idade
Pneumonia Aspirativa/etiologia
Recidiva
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anti-Bacterial Agents)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180102
[Lr] Data última revisão:
180102
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170428
[St] Status:MEDLINE
[do] DOI:10.4166/kjg.2017.69.4.226


  2 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28711629
[Au] Autor:Snyder GM; Wright SB; Smithey A; Mizrahi M; Sheppard M; Hirsch EB; Chuttani R; Heroux R; Yassa DS; Olafsdottir LB; Davis RB; Anastasiou J; Bapat V; Bidari K; Pleskow DK; Leffler D; Lane B; Chen A; Gold HS; Bartley A; King AD; Sawhney MS
[Ad] Endereço:Division of Infection Control/Hospital Epidemiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
[Ti] Título:Randomized Comparison of 3 High-Level Disinfection and Sterilization Procedures for Duodenoscopes.
[So] Source:Gastroenterology;153(4):1018-1025, 2017 Oct.
[Is] ISSN:1528-0012
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND AND AIMS: Duodenoscopes have been implicated in the transmission of multidrug-resistant organisms (MDRO). We compared the frequency of duodenoscope contamination with MDRO or any other bacteria after disinfection or sterilization by 3 different methods. METHODS: We performed a single-center prospective randomized study in which duodenoscopes were randomly reprocessed by standard high-level disinfection (sHLD), double high-level disinfection (dHLD), or standard high-level disinfection followed by ethylene oxide gas sterilization (HLD/ETO). Samples were collected from the elevator mechanism and working channel of each duodenoscope and cultured before use. The primary outcome was the proportion of duodenoscopes with an elevator mechanism or working channel culture showing 1 or more MDRO; secondary outcomes included the frequency of duodenoscope contamination with more than 0 and 10 or more colony-forming units (CFU) of aerobic bacterial growth on either sampling location. RESULTS: After 3 months of enrollment, the study was closed because of the futility; we did not observe sufficient events to evaluate the primary outcome. Among 541 duodenoscope culture events, 516 were included in the final analysis. No duodenoscope culture in any group was positive for MDRO. Bacterial growth of more than 0 CFU was noted in 16.1% duodenoscopes in the sHLD group, 16.0% in the dHLD group, and 22.5% in the HLD/ETO group (P = .21). Bacterial growth or 10 or more CFU was noted in 2.3% of duodenoscopes in the sHLD group, 4.1% in the dHLD group, and 4.2% in the HLD/ETO group (P = .36). MRDOs were cultured from 3.2% of pre-procedure rectal swabs and 2.5% of duodenal aspirates. CONCLUSIONS: In a comparison of duodenoscopes reprocessed by sHLD, dHLD, or HLD/ETO, we found no significant differences between groups for MDRO or bacteria contamination. Enhanced disinfection methods (dHLD or HLD/ETO) did not provide additional protection against contamination. However, insufficient events occurred to assess our primary study end-point. ClinicalTrials.gov no: NCT02611648.
[Mh] Termos MeSH primário: Infecção Hospitalar/prevenção & controle
Desinfetantes
Desinfecção/métodos
Farmacorresistência Bacteriana Múltipla
Duodenoscópios/microbiologia
Duodenoscopia/instrumentação
Contaminação de Equipamentos/prevenção & controle
Reutilização de Equipamento
Óxido de Etileno
Esterilização/métodos
o-Ftalaldeído
[Mh] Termos MeSH secundário: Técnicas Bacteriológicas
Infecção Hospitalar/microbiologia
Infecção Hospitalar/transmissão
Duodenoscópios/efeitos adversos
Duodenoscopia/efeitos adversos
Gases
Seres Humanos
Estudos Prospectivos
Fatores de Tempo
[Pt] Tipo de publicação:COMPARATIVE STUDY; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Disinfectants); 0 (Gases); 643-79-8 (o-Phthalaldehyde); JJH7GNN18P (Ethylene Oxide)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171016
[Lr] Data última revisão:
171016
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170717
[St] Status:MEDLINE


  3 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28679982
[Au] Autor:Iwamuro M; Oka S; Kanzaki H; Tanaka T; Kawano S; Kawahara Y; Okada H
[Ad] Endereço:Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.
[Ti] Título:Pseudomelanosis duodeni:a case report.
[So] Source:Nihon Shokakibyo Gakkai Zasshi;114(7):1264-1268, 2017.
[Is] ISSN:0446-6586
[Cp] País de publicação:Japan
[La] Idioma:jpn
[Ab] Resumo:An 83-year-old Japanese man underwent esophagogastroduodenoscopy for screening purposes. He had a medical history of hypertension, chronic kidney disease, chronic heart failure, and chronic myeloid leukemia, and he had been taking the following medications:ferrous citrate, furosemide, spironolactone, tolvaptan, bisoprolol, nicorandil, warfarin, nilotinib, febuxostat, esomeprazole, digestive enzyme complex, ambroxol, carbocysteine, and potassium L-aspartate. Esophagogastroduodenoscopy revealed a brownish speckled pigmentation in the duodenal bulb. Biopsy specimens from the duodenal villi revealed a brown pigment deposition, which appeared bright on scanning electron microscopy. Energy dispersive X-ray spectroscopy and elemental mapping revealed the presence of iron and sulfur in the duodenal villi. Consequently, pseudomelanosis duodeni was diagnosed based on these findings.
[Mh] Termos MeSH primário: Duodenopatias/diagnóstico por imagem
Melanose/diagnóstico por imagem
[Mh] Termos MeSH secundário: Idoso de 80 Anos ou mais
Biópsia
Duodenopatias/patologia
Duodenoscopia
Seres Humanos
Masculino
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170707
[St] Status:MEDLINE
[do] DOI:10.11405/nisshoshi.114.1264


  4 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28541146
[Au] Autor:Smith TG; Wu X; Ellison JA; Wadhwa A; Franka R; Langham GL; Skinner BL; Hanlon CA; Bronshtein VL
[Ti] Título:Assessment of the immunogenicity of rabies vaccine preserved by vaporization and delivered to the duodenal mucosa of gray foxes (Urocyon cinereoargenteus).
[So] Source:Am J Vet Res;78(6):752-756, 2017 Jun.
[Is] ISSN:1943-5681
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE To assess the immunogenicity of thermostable live-attenuated rabies virus (RABV) preserved by vaporization (PBV) and delivered to the duodenal mucosa of a wildlife species targeted for an oral vaccination program. ANIMALS 8 gray foxes (Urocyon cinereoargenteus). PROCEDURES Endoscopy was used to place RABV PBV (n = 3 foxes), alginate-encapsulated RABV PBV (3 foxes), or nonpreserved RABV (2 foxes) vaccine into the duodenum of foxes. Blood samples were collected weekly to monitor the immune response. Saliva samples were collected weekly and tested for virus shedding by use of a conventional reverse-transcriptase PCR assay. Foxes were euthanized 28 days after vaccine administration, and relevant tissues were collected and tested for presence of RABV. RESULTS 2 of 3 foxes that received RABV PBV and 1 of 2 foxes that received nonpreserved RABV seroconverted by day 28. None of the 3 foxes receiving alginate-encapsulated RABV PBV seroconverted. No RABV RNA was detected in saliva at any of the time points, and RABV antigen or RNA was not detected in any of the tissues obtained on day 28. None of the foxes displayed any clinical signs of rabies. CONCLUSIONS AND CLINICAL RELEVANCE Results for this study indicated that a live-attenuated RABV vaccine delivered to the duodenal mucosa can induce an immune response in gray foxes. A safe, potent, thermostable RABV vaccine that could be delivered orally to wildlife or domestic animals would enhance current rabies control and prevention efforts.
[Mh] Termos MeSH primário: Duodeno
Raposas
Imunogenicidade da Vacina
Vacinas Antirrábicas/imunologia
[Mh] Termos MeSH secundário: Administração Oral
Animais
Animais Selvagens
Antígenos Virais
Duodenoscopia/veterinária
Duodeno/imunologia
Feminino
Mucosa Intestinal/imunologia
Masculino
Vacinas Antirrábicas/administração & dosagem
Vacinas Atenuadas/imunologia
Volatilização
[Pt] Tipo de publicação:CLINICAL TRIAL; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antigens, Viral); 0 (Rabies Vaccines); 0 (Vaccines, Attenuated)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171017
[Lr] Data última revisão:
171017
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170526
[St] Status:MEDLINE
[do] DOI:10.2460/ajvr.78.6.752


  5 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28478708
[Au] Autor:Abdallah FF; Serracino-Inglott F; Ananthakrishnan G
[Ad] Endereço:1 Regional Vascular and Endovascular Unit, Central Manchester University Hospital Foundation Trust, Manchester, United Kingdom.
[Ti] Título:Giant Hepatic Aneurysm Presenting With Hematemesis Successfully Treated With an Endovascular Technique.
[So] Source:Vasc Endovascular Surg;51(5):331-334, 2017 Jul.
[Is] ISSN:1938-9116
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Hepatic artery aneurysms are uncommon visceral aneurysms that are usually found incidentally on imaging. We present a case of large common hepatic aneurysm presenting with life-threatening hematemesis due to duodenal erosion, in a 66-year-old man, treated by embolization with Onyx and coils while preserving hepatic perfusion.
[Mh] Termos MeSH primário: Aneurisma/terapia
Duodenopatias/etiologia
Hematemese/etiologia
Artéria Hepática
[Mh] Termos MeSH secundário: Idoso
Aneurisma/complicações
Aneurisma/diagnóstico por imagem
Angiografia Digital
Aortografia/métodos
Angiografia por Tomografia Computadorizada
Dimetil Sulfóxido/administração & dosagem
Duodenopatias/diagnóstico
Duodenoscopia
Embolização Terapêutica/instrumentação
Embolização Terapêutica/métodos
Artéria Hepática/diagnóstico por imagem
Seres Humanos
Masculino
Polivinil/administração & dosagem
Radiografia Intervencionista
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Onyx copolymer); 0 (Polyvinyls); YOW8V9698H (Dimethyl Sulfoxide)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170509
[St] Status:MEDLINE
[do] DOI:10.1177/1538574417707145


  6 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
[PMID]:28444987
[Au] Autor:Colli A; Gana JC; Yap J; Adams-Webber T; Rashkovan N; Ling SC; Casazza G
[Ad] Endereço:Department of Internal Medicine, A Manzoni Hospital ASST Lecco, Via dell'Eremo, 9/11, Lecco, Italy, 23900.
[Ti] Título:Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.
[So] Source:Cochrane Database Syst Rev;4:CD008759, 2017 Apr 26.
[Is] ISSN:1469-493X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Current guidelines recommend screening of people with oesophageal varices via oesophago-gastro-duodenoscopy at the time of diagnosis of hepatic cirrhosis. This requires that people repeatedly undergo unpleasant invasive procedures with their attendant risks, although half of these people have no identifiable oesophageal varices 10 years after the initial diagnosis of cirrhosis. Platelet count, spleen length, and platelet count-to-spleen length ratio are non-invasive tests proposed as triage tests for the diagnosis of oesophageal varices. OBJECTIVES: Primary objectives To determine the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices of any size in paediatric or adult patients with chronic liver disease or portal vein thrombosis, irrespective of aetiology. To investigate the accuracy of these non-invasive tests as triage or replacement of oesophago-gastro-duodenoscopy. Secondary objectives To compare the diagnostic accuracy of these same tests for the diagnosis of high-risk oesophageal varices in paediatric or adult patients with chronic liver disease or portal vein thrombosis, irrespective of aetiology.We aimed to perform pair-wise comparisons between the three index tests, while considering predefined cut-off values.We investigated sources of heterogeneity. SEARCH METHODS: The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Hepato-Biliary Group Diagnostic Test Accuracy Studies Register, the Cochrane Library, MEDLINE (OvidSP), Embase (OvidSP), and Science Citation Index - Expanded (Web of Science) (14 June 2016). We applied no language or document-type restrictions. SELECTION CRITERIA: Studies evaluating the diagnostic accuracy of platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices via oesophago-gastro-duodenoscopy as the reference standard in children or adults of any age with chronic liver disease or portal vein thrombosis, who did not have variceal bleeding. DATA COLLECTION AND ANALYSIS: Standard Cochrane methods as outlined in the Cochrane Handbook for Diagnostic Test of Accuracy Reviews. MAIN RESULTS: We included 71 studies, 67 of which enrolled only adults and four only children. All included studies were cross-sectional and were undertaken at a tertiary care centre. Eight studies reported study results in abstracts or letters. We considered all but one of the included studies to be at high risk of bias. We had major concerns about defining the cut-off value for the three index tests; most included studies derived the best cut-off values a posteriori, thus overestimating accuracy; 16 studies were designed to validate the 909 (n/mm /mm cut-off value for platelet count-to-spleen length ratio. Enrolment of participants was not consecutive in six studies and was unclear in 31 studies. Thirty-four studies assessed enrolment consecutively. Eleven studies excluded some included participants from the analyses, and in only one study, the time interval between index tests and the reference standard was longer than three months. Diagnosis of varices of any size. Platelet count showed sensitivity of 0.71 (95% confidence interval (CI) 0.63 to 0.77) and specificity of 0.80 (95% CI 0.69 to 0.88) (cut-off value of around 150,000/mm from 140,000 to 150,000/mm ; 10 studies, 2054 participants). When examining potential sources of heterogeneity, we found that of all predefined factors, only aetiology had a role: studies including participants with chronic hepatitis C reported different results when compared with studies including participants with mixed aetiologies (P = 0.036). Spleen length showed sensitivity of 0.85 (95% CI 0.75 to 0.91) and specificity of 0.54 (95% CI 0.46 to 0.62) (cut-off values of around 110 mm, from 110 to 112.5 mm; 13 studies, 1489 participants). Summary estimates for detection of varices of any size showed sensitivity of 0.93 (95% CI 0.83 to 0.97) and specificity of 0.84 (95% CI 0.75 to 0.91) in 17 studies, and 2637 participants had a cut-off value for platelet count-to-spleen length ratio of 909 (n/mm )/mm. We found no effect of predefined sources of heterogeneity. An overall indirect comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length ratio was the most accurate index test when compared with platelet count (P < 0.001) and spleen length (P < 0.001). Diagnosis of varices at high risk of bleeding. Platelet count showed sensitivity of 0.80 (95% CI 0.73 to 0.85) and specificity of 0.68 (95% CI 0.57 to 0.77) (cut-off value of around 150,000/mm from 140,000 to 160,000/mm ; seven studies, 1671 participants). For spleen length, we obtained only a summary ROC curve as we found no common cut-off between studies (six studies, 883 participants). Platelet count-to-spleen length ratio showed sensitivity of 0.85 (95% CI 0.72 to 0.93) and specificity of 0.66 (95% CI 0.52 to 0.77) (cut-off value of around 909 (n/mm )/mm; from 897 to 921 (n/mm )/mm; seven studies, 642 participants). An overall indirect comparison of the HSROCs of the three index tests showed that platelet count-to-spleen length ratio was the most accurate index test when compared with platelet count (P = 0.003) and spleen length (P < 0.001). DIagnosis of varices of any size in children. We found four studies including 277 children with different liver diseases and or portal vein thrombosis. Platelet count showed sensitivity of 0.71 (95% CI 0.60 to 0.80) and specificity of 0.83 (95% CI 0.70 to 0.91) (cut-off value of around 115,000/mm ; four studies, 277 participants). Platelet count-to-spleen length z-score ratio showed sensitivity of 0.74 (95% CI 0.65 to 0.81) and specificity of 0.64 (95% CI 0.36 to 0.84) (cut-off value of 25; two studies, 197 participants). AUTHORS' CONCLUSIONS: Platelet count-to-spleen length ratio could be used to stratify the risk of oesophageal varices. This test can be used as a triage test before endoscopy, thus ruling out adults without varices. In the case of a ratio > 909 (n/mm )/mm, the presence of oesophageal varices of any size can be excluded and only 7% of adults with varices of any size would be missed, allowing investigators to spare the number of oesophago-gastro-duodenoscopy examinations. This test is not accurate enough for identification of oesophageal varices at high risk of bleeding that require primary prophylaxis. Future studies should assess the diagnostic accuracy of this test in specific subgroups of patients, as well as its ability to predict variceal bleeding. New non-invasive tests should be examined.
[Mh] Termos MeSH primário: Duodenoscopia
Varizes Esofágicas e Gástricas/diagnóstico
Hepatopatias/complicações
Contagem de Plaquetas
Veia Porta
Baço/anatomia & histologia
Trombose Venosa/complicações
[Mh] Termos MeSH secundário: Adulto
Criança
Doença Crônica
Varizes Esofágicas e Gástricas/sangue
Varizes Esofágicas e Gástricas/patologia
Hepatite C Crônica/complicações
Seres Humanos
Tamanho do Órgão
Ensaios Clínicos Controlados Aleatórios como Assunto
Sensibilidade e Especificidade
Triagem
[Pt] Tipo de publicação:JOURNAL ARTICLE; META-ANALYSIS; REVIEW
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170726
[Lr] Data última revisão:
170726
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170427
[St] Status:MEDLINE
[do] DOI:10.1002/14651858.CD008759.pub2


  7 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28292408
[Au] Autor:Cherrington AD; Rajagopalan H; Maggs D; Devière J
[Ad] Endereço:Molecular Physiology & Biophysics, Vanderbilt University School of Medicine, 704A/710 Robinson Research Building, 2200 Pierce Avenue, Nashville, TN 37232-0615, USA. Electronic address: alan.cherrington@vanderbilt.edu.
[Ti] Título:Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease.
[So] Source:Gastrointest Endosc Clin N Am;27(2):299-311, 2017 Apr.
[Is] ISSN:1558-1950
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The duodenum has become recognized as a metabolic signaling center that is involved in regulating insulin action and, therefore, insulin resistance states such as type 2 diabetes. Bariatric surgery and other manipulations of the upper intestine, in particular the duodenum, have shown that limiting nutrient exposure or contact in this key region exerts powerful metabolic effects. Early human clinical trial data suggest that endoscopic hydrothermal duodenal mucosal resurfacing is well tolerated in human subjects and has an acceptable safety profile. This article describes the rationale for this endoscopic approach and its early human use, including safety, tolerability, and early efficacy.
[Mh] Termos MeSH primário: Cirurgia Bariátrica/métodos
Ablação por Cateter/métodos
Duodenoscopia/métodos
Duodeno/cirurgia
Mucosa Intestinal/cirurgia
[Mh] Termos MeSH secundário: Diabetes Mellitus Tipo 2/cirurgia
Fígado Gorduroso/cirurgia
Seres Humanos
Resistência à Insulina
Síndrome Metabólica/cirurgia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171116
[Lr] Data última revisão:
171116
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170316
[St] Status:MEDLINE


  8 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28135794
[Au] Autor:Kim DK; Moon HS; Jung HY; Sung JK; Gang SH; Kim MH
[Ad] Endereço:Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chungnam National University of Medicine, Daejeon, Korea.
[Ti] Título:An Incidental Discovery of Morgagni Hernia in an Elderly Patient Presented with Chronic Dyspepsia.
[So] Source:Korean J Gastroenterol;69(1):68-73, 2017 Jan 25.
[Is] ISSN:2233-6869
[Cp] País de publicação:Korea (South)
[La] Idioma:eng
[Ab] Resumo:A Morgagni hernia was first described in 1761 by Giovanni Morgagni. In adults, it is accompanied by gastrointestinal- or respiratory-type symptoms. Herein, we report an 84-year-old woman presented to our hospital with nausea and vomiting. After hospitalization, an X-ray revealed a right diaphragmatic hernia. Based on the results of abdominal computed tomography, duodenoscopy, and upper gastrointestinography (gastrografin), we concluded that her symptoms were caused by Morgagni hernia. Our patient underwent laparoscopic surgery, and shortly thereafter, her symptoms resolved.
[Mh] Termos MeSH primário: Dispepsia/diagnóstico
Hérnias Diafragmáticas Congênitas/diagnóstico
[Mh] Termos MeSH secundário: Idoso de 80 Anos ou mais
Diatrizoato de Meglumina/química
Duodenoscopia
Dispepsia/complicações
Feminino
Hérnias Diafragmáticas Congênitas/complicações
Hérnias Diafragmáticas Congênitas/diagnóstico por imagem
Seres Humanos
Laparoscopia
Náusea/etiologia
Tomografia Computadorizada por Raios X
Vômito/etiologia
[Pt] Tipo de publicação:CASE REPORTS
[Nm] Nome de substância:
3X9MR4N98U (Diatrizoate Meglumine)
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170201
[St] Status:MEDLINE
[do] DOI:10.4166/kjg.2017.69.1.68


  9 / 2917 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28134720
[Au] Autor:Bruns MA; Gibbs ER
[Ad] Endereço:Mark A. Bruns, MHA, RN, CGRN, is Nurse Clinician, GI Lab, Mercy Hospital St. Louis, Missouri. Elizabeth R. Gibbs, MPH, MT, CIC, is Senior Clinical Quality Measures Specialist, Mercy Quality and Safety Center, Mercy Hospital St. Louis, Missouri.
[Ti] Título:Multidepartmental Response to a Duodenoscope Used on a CRE Patient: A Case Study.
[So] Source:Gastroenterol Nurs;40(1):56-62, 2017 Jan/Feb.
[Is] ISSN:1538-9766
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Transmission of carbapenem-resistant Enterobacteriaceae (CRE) via duodenoscopes, specialized endoscopes used during endoscopic retrograde cholangiopancreatography (ERCP) procedures, has attracted media attention since early 2015. This attention has placed increasing focus on the reprocessing of duodenoscopes. Current reprocessing recommendations for these endoscopes require either high-level disinfection or ethylene oxide sterilization. While reprocessing duodenoscopes, staff at endoscopy locations within the Mercy health system perform a single high-level disinfection cycle that is preceded by two cycles of manual cleaning. The Mercy system has 37 locations for gastrointestinal endoscopic procedures and nine that can accommodate patients requiring ERCP. In early 2016, the Mercy Oklahoma City location performed an ERCP on a patient known prior to the case to be a carrier of CRE. After the case, multiple departments located in both the Oklahoma City and St. Louis facilities partnered to culture and sterilize the duodenoscope used in that case to ensure its safety for use on subsequent patients. This case study presents the situation and discusses culturing of endoscopes. In light of the evidence presented, the importance of enhanced communication and cooperation to achieve patient safety should be paramount to all other factors.
[Mh] Termos MeSH primário: Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos
Infecção Hospitalar/epidemiologia
Duodenoscópios/microbiologia
Infecções por Enterobacteriaceae/transmissão
Enterobacteriaceae/isolamento & purificação
Contaminação de Equipamentos/prevenção & controle
[Mh] Termos MeSH secundário: Carbapenêmicos/administração & dosagem
Colangiopancreatografia Retrógrada Endoscópica/instrumentação
Infecção Hospitalar/microbiologia
Farmacorresistência Bacteriana
Duodenoscopia/efeitos adversos
Duodenoscopia/instrumentação
Enterobacteriaceae/efeitos dos fármacos
Feminino
Seres Humanos
Incidência
Masculino
Determinação de Necessidades de Cuidados de Saúde
Medição de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Carbapenems)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170919
[Lr] Data última revisão:
170919
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:170131
[St] Status:MEDLINE
[do] DOI:10.1097/SGA.0000000000000268


  10 / 2917 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28099033
[Au] Autor:Páez Cumpa C; Erimeiku Barahona A; Payeras Capó MA; Amengual Antich I; Garrido Durán C
[Ad] Endereço:Digestivo, Hospital Universitario Son Espases, España.
[Ti] Título:Hemobilia due to intracholecystic papillary neoplasm.
[So] Source:Rev Esp Enferm Dig;109(1):70-73, 2017 Jan.
[Is] ISSN:1130-0108
[Cp] País de publicação:Spain
[La] Idioma:eng
[Ab] Resumo:We report the case of a 39-year-old patient who presented an episode of upper gastrointestinal bleeding due to hemobilia. The imaging tests showed the gallbladder occupied by solid tissue, with a diagnosis of intracholecystic papillary neoplasm after the cholecystectomy. The intracholecystic papillary neoplasm of the gallbladder is a newly established entity and it is considered a subtype of intraductal papillary neoplasm of the bile duct. Its presentation in the form of hemobilia has barely been described in the literature.
[Mh] Termos MeSH primário: Adenocarcinoma Papilar/complicações
Neoplasias dos Ductos Biliares/complicações
Hemobilia/etiologia
[Mh] Termos MeSH secundário: Adenocarcinoma Papilar/diagnóstico por imagem
Adenocarcinoma Papilar/cirurgia
Adulto
Neoplasias dos Ductos Biliares/diagnóstico por imagem
Neoplasias dos Ductos Biliares/cirurgia
Colecistectomia
Duodenoscopia
Hemobilia/diagnóstico por imagem
Seres Humanos
Masculino
Tomografia Computadorizada por Raios X
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171102
[Lr] Data última revisão:
171102
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170119
[St] Status:MEDLINE
[do] DOI:10.17235/reed.2016.4205/2016



página 1 de 292 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde